Related Experiment Video

Updated: Jul 8, 2026

An Orthotopic Bladder Cancer Model for Gene Delivery Studies
07:48

An Orthotopic Bladder Cancer Model for Gene Delivery Studies

Published on: December 1, 2013

Viral and nonviral gene delivery vectors for cancer gene therapy

R J Cristiano1, B Xu, D Nguyen

  • 1Department of Thoracic and Cardiovascular Surgery, The University of Texas M. D. Anderson Cancer Center, Houston 77030, USA.

Cancer Detection and Prevention
|September 4, 1998
PubMed

Insights

Researchers developed novel viral and nonviral vectors for cancer gene therapy. These vectors efficiently deliver therapeutic genes, suppressing tumor growth and inducing apoptosis, offering improved cancer treatment strategies.

Area of Science:

  • Oncology
  • Gene Therapy
  • Molecular Biology

Background:

  • Efficient gene delivery vectors are essential for successful gene therapy.
  • Cancer gene therapy aims to correct genetic abnormalities driving malignant transformation.

Purpose of the Study:

  • To develop and evaluate recombinant viral and nonviral vectors for targeted cancer gene therapy.
  • To assess the efficacy of these vectors in correcting genetic defects and suppressing tumor growth.

Main Methods:

  • Development of recombinant adenovirus (Adv) and epidermal growth factor (EGF)/DNA complexes.
  • Transduction of cancer cells with Adv/p53 to express tumor suppressor p53.
  • Pre-treatment of cancer cells with cisplatin to enhance Adv transduction.
  • Targeting EGF/DNA complexes to lung cancer cells overexpressing EGF receptors.

Main Results:

  • Adv transduction efficiency varied with virus-to-cell ratio.
  • Adv/p53 expression effectively suppressed tumor cell growth and induced apoptosis in vitro and in vivo.
  • Cisplatin pre-treatment enhanced therapeutic gene expression from Adv vectors.
  • EGF/DNA complexes achieved efficient transduction of lung cancer cell lines.

Conclusions:

  • Developed viral and nonviral vectors show promise for cancer gene therapy.
  • Targeted delivery and enhanced transduction methods improve therapeutic gene expression.
  • These vectors offer improved strategies for clinical cancer treatment.

More Related Videos

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

Non-Viral Engineering of Primary Human T Cells via Homology-Mediated End-Joining Targeted Integration of Large DNA Templates06:10

Non-Viral Engineering of Primary Human T Cells via Homology-Mediated End-Joining Targeted Integration of Large DNA Templates

Published on: May 9, 2025

Related Concept Videos

Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.